S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

KNSA Kiniksa Pharmaceuticals International PLC

26.56

1.07 (4.20%)

12 Oct 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Kiniksa Pharmaceuticals Charts.

Kiniksa Pharmaceuticals International PLC News

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 9 October 2024 (3 days ago) • Edgar (US Regulatory)

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
Tuesday 1 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 26 September 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 24 September 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (1 month ago) • Edgar (US Regulatory)

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
Thursday 29 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Wednesday 24 July 2024 (3 months ago) • Edgar (US Regulatory)

Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend]
Wednesday 24 July 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 24 July 2024 (3 months ago) • Edgar (US Regulatory)

More Kiniksa Pharmaceuticals International PLC News Articles

Woodside Petroleum

AUD vs US Dollar

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions